These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1143 related articles for article (PubMed ID: 33767397)

  • 1. Engineering luminescent biosensors for point-of-care SARS-CoV-2 antibody detection.
    Elledge SK; Zhou XX; Byrnes JR; Martinko AJ; Lui I; Pance K; Lim SA; Glasgow JE; Glasgow AA; Turcios K; Iyer NS; Torres L; Peluso MJ; Henrich TJ; Wang TT; Tato CM; Leung KK; Greenhouse B; Wells JA
    Nat Biotechnol; 2021 Aug; 39(8):928-935. PubMed ID: 33767397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering luminescent biosensors for point-of-care SARS-CoV-2 antibody detection.
    Elledge SK; Zhou XX; Byrnes JR; Martinko AJ; Lui I; Pance K; Lim SA; Glasgow JE; Glasgow AA; Turcios K; Iyer N; Torres L; Peluso MJ; Henrich TJ; Wang TT; Tato CM; Leung KK; Greenhouse B; Wells JA
    medRxiv; 2020 Aug; ():. PubMed ID: 32839788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serological assays and host antibody detection in coronavirus-related disease diagnosis.
    Dowlatshahi S; Shabani E; Abdekhodaie MJ
    Arch Virol; 2021 Mar; 166(3):715-731. PubMed ID: 33492524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A rapid, point-of-care red blood cell agglutination assay detecting antibodies against SARS-CoV-2.
    Kruse RL; Huang Y; Smetana H; Gehrie EA; Amukele TK; Tobian AAR; Mostafa HH; Wang ZZ
    Biochem Biophys Res Commun; 2021 May; 553():165-171. PubMed ID: 33773139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 Antibody Rapid Tests: Valuable Epidemiological Tools in Challenging Settings.
    Saluzzo F; Mantegani P; Poletti De Chaurand V; Quaresima V; Cugnata F; Di Serio C; Macé A; De Vos M; Sacks JA; Cirillo DM
    Microbiol Spectr; 2021 Oct; 9(2):e0025021. PubMed ID: 34549999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of SARS-CoV-2-specific antibodies via rapid diagnostic immunoassays in COVID-19 patients.
    Chansaenroj J; Yorsaeng R; Posuwan N; Puenpa J; Sudhinaraset N; Chirathaworn C; Poovorawan Y
    Virol J; 2021 Mar; 18(1):52. PubMed ID: 33750394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remote Fingerstick Blood Collection for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Testing.
    Garcia-Beltran WF; Miller TE; Kirkpatrick G; Nixon A; Astudillo MG; Yang D; Mahanta LM; Murali M; Dighe AS; Lennerz J; Thierauf J; Naranbhai V; Iafrate AJ
    Arch Pathol Lab Med; 2021 Apr; 145(4):415-418. PubMed ID: 33264390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a Surrogate Enzyme-Linked Immunosorbent Assay-Based Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) cPass Neutralization Antibody Detection Assay and Correlation With Immunoglobulin G Commercial Serology Assays.
    Nandakumar V; Profaizer T; Lozier BK; Elgort MG; Larragoite ET; Williams ESCP; Solis-Leal A; Lopez JB; Berges BK; Planelles V; Rychert J; Slev PR; Delgado JC
    Arch Pathol Lab Med; 2021 Oct; 145(10):1212-1220. PubMed ID: 34181714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Three Quantitative Anti-SARS-CoV-2 Antibody Immunoassays.
    Chapuy-Regaud S; Miédougé M; Abravanel F; Da Silva I; Porcheron M; Fillaux J; Diméglio C; Izopet J
    Microbiol Spectr; 2021 Dec; 9(3):e0137621. PubMed ID: 34937195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using Split Luminescent Biosensors for SARS-CoV-2 Antibody Detection in Serum, Plasma, and Blood Samples.
    Elledge SK; Eigl I; Phelps M; McClinton K; Zhou XX; Leung KK; Tato CM; Wells JA
    Curr Protoc; 2022 Oct; 2(10):e521. PubMed ID: 36200787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative review of immunoassays for COVID-19 detection.
    Mohit E; Rostami Z; Vahidi H
    Expert Rev Clin Immunol; 2021 Jun; 17(6):573-599. PubMed ID: 33787412
    [No Abstract]   [Full Text] [Related]  

  • 12. A Multiplex Noninvasive Salivary Antibody Assay for SARS-CoV-2 Infection and Its Application in a Population-Based Survey by Mail.
    Egorov AI; Griffin SM; Fuzawa M; Kobylanski J; Grindstaff R; Padgett W; Simmons S; Hallinger DR; Styles JN; Wickersham L; Sams E; Hudgens E; Wade TJ
    Microbiol Spectr; 2021 Oct; 9(2):e0069321. PubMed ID: 34523986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Assessment of Serological Assays for SARS-CoV-2 as Surrogates for Authentic Virus Neutralization.
    Wohlgemuth N; Whitt K; Cherry S; Kirkpatrick Roubidoux E; Lin CY; Allison KJ; Gowen A; Freiden P; Allen EK; ; Gaur AH; Estepp JH; Tang L; Mori T; Hijano DR; Hakim H; McGargill MA; Krammer F; Whitt MA; Wolf J; Thomas PG; Schultz-Cherry S
    Microbiol Spectr; 2021 Oct; 9(2):e0105921. PubMed ID: 34704832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Commercial Rapid Lateral Flow Tests, Alone or in Combination, for SARS-CoV-2 Antibody Testing.
    Fischer PU; Fischer K; Curtis KC; Huang Y; Fetcho N; Goss CW; Weil GJ
    Am J Trop Med Hyg; 2021 Jun; 105(2):378-386. PubMed ID: 34181574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of SARS-CoV-2 Antibodies in Oral Fluid Obtained Using a Rapid Collection Device.
    MacMullan MA; Chellamuthu P; Mades A; Das S; Turner F; Slepnev VI; Ibrayeva A
    J Clin Microbiol; 2021 Jan; 59(2):. PubMed ID: 33234589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inference of SARS-CoV-2 spike-binding neutralizing antibody titers in sera from hospitalized COVID-19 patients by using commercial enzyme and chemiluminescent immunoassays.
    Valdivia A; Torres I; Latorre V; Francés-Gómez C; Albert E; Gozalbo-Rovira R; Alcaraz MJ; Buesa J; Rodríguez-Díaz J; Geller R; Navarro D
    Eur J Clin Microbiol Infect Dis; 2021 Mar; 40(3):485-494. PubMed ID: 33404891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual lateral flow optical/chemiluminescence immunosensors for the rapid detection of salivary and serum IgA in patients with COVID-19 disease.
    Roda A; Cavalera S; Di Nardo F; Calabria D; Rosati S; Simoni P; Colitti B; Baggiani C; Roda M; Anfossi L
    Biosens Bioelectron; 2021 Jan; 172():112765. PubMed ID: 33126179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testing-on-a-probe biosensors reveal association of early SARS-CoV-2 total antibodies and surrogate neutralizing antibodies with mortality in COVID-19 patients.
    Yang HS; Racine-Brzostek SE; Karbaschi M; Yee J; Dillard A; Steel PAD; Lee WT; McDonough KA; Qiu Y; Ketas TJ; Francomano E; Klasse PJ; Hatem L; Westblade L; Wu H; Chen H; Zuk R; Tan H; Girardin RC; Dupuis AP; Payne AF; Moore JP; Cushing MM; Chadburn A; Zhao Z
    Biosens Bioelectron; 2021 Apr; 178():113008. PubMed ID: 33515984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance evaluation of antibody-based point-of-care devices intended for the identification of immune responses to SARS-CoV-2.
    Furuya AKM; Wagner C; Connors J; Bodnar J; Miller T; Ryman NL; Warszycki CJ; Wong SJ; Walsh AC; McDonough KA; Lee WT
    Diagn Microbiol Infect Dis; 2021 Apr; 99(4):115298. PubMed ID: 33418405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How to interpret and use COVID-19 serology and immunology tests.
    Ong DSY; Fragkou PC; Schweitzer VA; Chemaly RF; Moschopoulos CD; Skevaki C;
    Clin Microbiol Infect; 2021 Jul; 27(7):981-986. PubMed ID: 33975005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 58.